Application of Quantitative Systems Pharmacology to Pediatric Drug Safety Assessment

被引：0
|
作者：
Samuels, Sherbet [1 ]
Bai, Jane P. F. [1 ]
Green, Dionna J. [2 ]
Abulwerdi, Gelareh [1 ]
Burckart, Gilbert J. [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Silver Spring, MD 20993 USA
[2] US FDA, Off Pediat Therapeut, Off Commissioner, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 114卷 / 04期
关键词：
D O I：
10.1002/cpt.2990
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The challenges with identifying and addressing drug safety concerns in the pediatric population are compounded by physiological and maturational factors. With their mechanistic and multiscale capabilities, quantitative systems pharmacology (QSP) models are well-poised to support critical pediatric drug safety assessments and decision making. However, we must be mindful of the opportunities and limitations of use of QSP models in this space. Herein, we discuss considerations for QSP models to support pediatric drug safety assessments.
引用
收藏
页码：748 / 750
页数：3
相关论文
共 50 条
  • [1] Systems pharmacology to predict drug safety in drug development
    Trame, Mirjam N.
    Biliouris, Konstantinos
    Lesko, Lawrence J.
    Mettetal, Jerome T.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 94 : 93 - 95
  • [2] Improving drug safety with a systems pharmacology approach
    Schotland, Peter
    Bojunga, Niels
    Zien, Alexander
    Trame, Mirjam Nadine
    Lesko, Lawrence J.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 94 : 84 - 92
  • [3] Systems Pharmacology Augments Drug Safety Surveillance
    Lorberbaum, T.
    Nasir, M.
    Keiser, M. J.
    Vilar, S.
    Hripcsak, G.
    Tatonetti, N. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (02) : 151 - 158
  • [4] Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
    Ewart, Lorna
    Dehne, Eva-Maria
    Fabre, Kristin
    Gibbs, Susan
    Hickman, James
    Hornberg, Ellinor
    Ingelman-Sundberg, Magnus
    Jang, Kyung-Jin
    Jones, David R.
    Lauschke, Volker M.
    Marx, Uwe
    Mettetal, Jerome T.
    Pointon, Amy
    Williams, Dominic
    Zimmermann, Wolfram-Hubertus
    Newham, Peter
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 65 - 82
  • [5] Application of ARE-reporter systems in drug discovery and safety assessment
    Deng, Tianqi
    Xu, Xiaoge
    Fu, Jingqi
    Xu, Yuanyuan
    Qu, Weidong
    Pi, Jingbo
    Wang, Huihui
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 454
  • [6] Quantitative Systems Pharmacology for Rare Disease Drug Development
    Bai, Jane P. F.
    Wang, Jie
    Zhang, Yifei
    Wang, Lingshan
    Jiang, Xiling
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (09) : 2313 - 2320
  • [7] Using quantitative systems pharmacology for novel drug discovery
    Perez-Nueno, Violeta I.
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (12) : 1315 - 1331
  • [8] The promises of quantitative systems pharmacology modelling for drug development
    Knight-Schrijver, V. R.
    Chelliah, V.
    Cucurull-Sanchez, L.
    Le Novere, N.
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2016, 14 : 363 - 370
  • [9] Systems pharmacology modeling: an approach to improving drug safety
    Bai, Jane P. F.
    Fontana, Robert J.
    Price, Nathan D.
    Sangar, Vineet
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (01) : 1 - 14
  • [10] Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
    Siler, Scott Q.
    PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1789 - 1802
12345